Latest agbiotech News | Page 4

Novotech earns renewed certification as an employer of choice for gender equality
AusBiotech 2024 National Conference Programme Unveiled
AusBiotech appoints senior leaders focused on advocacy, policy and elevating the voice of industry
Eminent cancer researcher confirmed as new Translational Research Institute CEO
PharmAust reports positive interim study results from study in ALS
Queensland researchers identify potential new treatment pathway for bladder cancer
Amplia says five patients recording sustained reduction in tumour size in trial
TGA seeks sector views on proposed changes to Essential Principles for medical devices
Noxopharm targets clinical trial for first-in-class investigative therapy
Chimeric says Phase 1/2 CHM CDH17 CAR-T GMP manufacturing complete
AusBioInvest 2024 Keynote Speaker Announced
Immutep announces first participant dosed in Phase 1 study of IMP761
Noxopharm announces CRO-67 results in complex pancreatic cancer studies
Remembering Industry Champion And Leader Dr Iris Depaz
AusBiotech selected as Industry Partner Organisation for Australia’s Industry Growth Program
CSL Reports Strong Profit Growth For Full Year 2024
‘We think the life sciences sector should be central to our national growth’
Federal Government announces National Science Statement and National Science and Research Priorities
Pfizer upgrades Melbourne plant making it one of the most advanced facilities in Australia
New funding available for quantum technologies and advanced manufacturing
Personalised cancer vaccines to be produced at new UQ lab
AusBiotech Announces Deputy CEO
Rosanne Hyland Appointed AusBiotech Deputy CEO
Imagion Biosystems announces changes to its board of directors
Pharmaceutical manufacturer tops revenue guidance in latest update
ANU Researchers Working To Unlock Full Potential Of RNA
AusBiotech Welcomes More New Members In Second Quarter
Monash welcomes funding for new national centre for mRNA medicines
Orthocell moves ahead on global market expansion with seven new regulatory applications
Telix completes significant raise that could be used for acquisitions
Remembering Nobel Laureate Professor Robin Warren AC
Neuren secures Rare Paediatric Disease Designation from FDA
Chimeric Therapeutics says first patient enrolled in cell therapy trial
Noxopharm Says Several Companies Evaluating Its Assets
New Perth Based RNA Facility To Improve Cancer Outcomes
Alterity Therapeutics reports positive interim data from Multiple System Atrophy trial
Burnet senior research officer awarded Moderna Global Fellowship
Queensland-based De Motu Cordis progresses development of innovative anaphylaxis treatment
Views sought in National Health and Medical Research Workforce Audit
Merck expands its fertility benefit to employees in New Zealand
Immutep reports positive results from trial of combination cancer therapy
Dimerix Awarded Bioshares Excellence Award
Orthocell receives regulatory approval to commence sales of Striate+ in Canada
Telix welcomes CMS proposal to improve payment for specialised diagnostic radiopharmaceuticals
Nominations sought for new shared MRFF and NHMRC advisory committees
Orthocell Reports Record Quarterly And Yearly Revenue
Genetic Technologies’ GeneType to enter Canadian and New Zealand markets
Dr James Campbell Appointed AusBiotech Chair